- Home
- ALXO vs LSF Comparison
ALXO vs LSF Comparison
Compare ALXO & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- LSF
- Stock Information
- Founded
- ALXO 2015
- LSF 2015
- Country
- ALXO United States
- LSF United States
- Employees
- ALXO N/A
- LSF N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- LSF Packaged Foods
- Sector
- ALXO Health Care
- LSF Consumer Staples
- Exchange
- ALXO Nasdaq
- LSF Nasdaq
- Market Cap
- ALXO 76.5M
- LSF 71.7M
- IPO Year
- ALXO 2020
- LSF 2020
- Fundamental
- Price
- ALXO $0.66
- LSF $6.28
- Analyst Decision
- ALXO Strong Buy
- LSF Strong Buy
- Analyst Count
- ALXO 6
- LSF 2
- Target Price
- ALXO $4.14
- LSF $7.75
- AVG Volume (30 Days)
- ALXO 1.4M
- LSF 110.1K
- Earning Date
- ALXO 03-06-2025
- LSF 05-07-2025
- Dividend Yield
- ALXO N/A
- LSF N/A
- EPS Growth
- ALXO N/A
- LSF N/A
- EPS
- ALXO N/A
- LSF N/A
- Revenue
- ALXO N/A
- LSF $43,295,137.00
- Revenue This Year
- ALXO N/A
- LSF $22.58
- Revenue Next Year
- ALXO N/A
- LSF $20.06
- P/E Ratio
- ALXO N/A
- LSF N/A
- Revenue Growth
- ALXO N/A
- LSF 26.50
- 52 Week Low
- ALXO $0.65
- LSF $1.90
- 52 Week High
- ALXO $17.83
- LSF $10.90
- Technical
- Relative Strength Index (RSI)
- ALXO 33.23
- LSF 50.84
- Support Level
- ALXO $0.65
- LSF $4.69
- Resistance Level
- ALXO $0.74
- LSF $7.35
- Average True Range (ATR)
- ALXO 0.07
- LSF 0.52
- MACD
- ALXO -0.00
- LSF 0.20
- Stochastic Oscillator
- ALXO 0.54
- LSF 59.77
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.